Search by Drug Name or NDC
NDC 65862-0596-02 Clindamycin Palmitate Hydrochloride (Pediatric) 75 mg/5mL Details
Clindamycin Palmitate Hydrochloride (Pediatric) 75 mg/5mL
Clindamycin Palmitate Hydrochloride (Pediatric) is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is CLINDAMYCIN PALMITATE HYDROCHLORIDE.
MedlinePlus Drug Summary
Clindamycin is used to treat certain types of bacterial infections, including infections of the lungs, skin, blood, female reproductive organs, and internal organs. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria. Antibiotics such as clindamycin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 65862-0596-02Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Clindamycin
Product Information
| NDC | 65862-0596 |
|---|---|
| Product ID | 65862-596_78e0ae1e-9c06-4831-b962-e1aa65546110 |
| Associated GPIs | 16220020222120 |
| GCN Sequence Number | 009346 |
| GCN Sequence Number Description | clindamycin palmitate HCl SOLN RECON 75 MG/5 ML ORAL |
| HIC3 | W1K |
| HIC3 Description | LINCOSAMIDE ANTIBIOTICS |
| GCN | 40860 |
| HICL Sequence Number | 019818 |
| HICL Sequence Number Description | CLINDAMYCIN PALMITATE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Clindamycin Palmitate Hydrochloride (Pediatric) |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clindamycin Palmitate Hydrochloride (Pediatric) |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 75 |
| Active Ingredient Units | mg/5mL |
| Substance Name | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202409 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 65862-0596-02 (65862059602)
| NDC Package Code | 65862-596-02 |
|---|---|
| Billing NDC | 65862059602 |
| Package | 1 BOTTLE, PLASTIC in 1 CARTON (65862-596-02) / 100 mL in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2022-11-14 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.18196 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | CLINDAMYCIN (PEDI) 75 MG/5 ML |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis